{
    "clinical_study": {
        "@rank": "129501", 
        "acronym": "EC2075", 
        "arm_group": {
            "arm_group_label": "indocyanine green", 
            "arm_group_type": "Experimental", 
            "description": "Indocyanine green is injected intravenously."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine if NIF fluoresent imaging is an effctive approch\n      to detect the margine of the breast tumoral tissue."
        }, 
        "brief_title": "ICG Distribution Using NIF Imaging After IV Injection of ICG in Benign and Malignant Breast Cancer Tissue.", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Breast Cancer.", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "Primary objective:\n\n      Definition of the histological distribution (intravascular, extra vascular, in specific\n      cells) of ICG (pre-operatively intra-venously injected) at the level of tumoral and healthy\n      tissues of breast cancer patients (and the potential of axillary lymph nodes found\n      fluorescent).\n\n      Secondary objectives:\n\n      Evaluation of the ability of the fluorescence imaging to determine the tumor volume and,\n      more specifically, the boundaries of tumor tissues which will be analyzed by the\n      pathologist.\n\n      Analysis of the correlation between fluorescence and \"margins\" as defined operatively as\n      tumor (microscopically by the pathologist)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with histopathological diagnosis of breast cancer for which a mastectomy\n             with axillary dissection is planned.\n\n          -  Informed Consent signed.\n\n        Exclusion Criteria:\n\n          -  Diagnosis of breast cancer established by lumpectomy or \"macro-biopsy\".\n\n          -  Operation after neo-adjuvant chemotherapy,\n\n          -  Age less than 18 years.\n\n          -  For pre-menopausal women, an operation planned for the second phase of their cycle.\n\n          -  Inability to give informed consent.\n\n          -  History of allergy or hypersensitivity to the investigational product, iodine.\n\n          -  Clinical or biological hyperthyroidism.\n\n          -  Known \"toxic\" thyroid nodules or known autonomous (hyperfunctional) thyroid.\n\n          -  A reported pathological coronary artery disease.\n\n          -  Creatinine > 1.5 mg / dl.\n\n          -  During the 2 weeks before surgery, being on medications which are known to interfere\n             with the ICG (ie anticonvulsants, heparin and haloperidol).\n\n          -  Pregnancy or breast feeding period."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01993576", 
            "org_study_id": "2013-000100-41"
        }, 
        "intervention": {
            "arm_group_label": "indocyanine green", 
            "description": "Intravenous injection of 0.25 mg/kg Indocyanine Green (ICG) before the surgery", 
            "intervention_name": "Indocyanine Green", 
            "intervention_type": "Drug", 
            "other_name": "ICG"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 20, 2013", 
        "location": {
            "contact": {
                "email": "pierre.bourgeois@bordet.be", 
                "last_name": "Pierre Bourgeois, Prof.", 
                "phone": "0032 2 541", 
                "phone_ext": "3276"
            }, 
            "contact_backup": {
                "email": "Dina.hertens@bordet.be", 
                "last_name": "Dina Hertens, Dr", 
                "phone": "0032 2541", 
                "phone_ext": "3164"
            }, 
            "facility": {
                "address": {
                    "city": "Brussels", 
                    "country": "Belgium", 
                    "zip": "B-1000"
                }, 
                "name": "Jules Bordet Insitute"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "1", 
        "official_title": "Histological Study of the (Intravenously Injected) ICG Distribution in Tumor Bearing Breasts and in Axillary Pieces of Dissection.", 
        "overall_contact": {
            "email": "pierre.bourgeois@bordet.be", 
            "last_name": "Pierre Bourgeois, MD, PhD", 
            "phone": "0032 2 541", 
            "phone_ext": "3276"
        }, 
        "overall_contact_backup": {
            "email": "dina.hertens@bordet.be", 
            "last_name": "Dina Hertens, MD", 
            "phone": "0032 2 541", 
            "phone_ext": "3781"
        }, 
        "overall_official": [
            {
                "affiliation": "Jules Bordet Institute", 
                "last_name": "Jean-Marie Nogaret, Prof.", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Jules Bordet Institute", 
                "last_name": "Isabelle Veys, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Jules Bordet Institute", 
                "last_name": "Sophie VanKerckhove, biologist", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Jules Bordet Institute", 
                "last_name": "Philippe De Neubourg, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Jules Bordet Institute", 
                "last_name": "Danielle Noterman, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Belgium: Federal Agency for Medicines and Health Products, FAMHP", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Detecting of the fluorescence in between benign and malignant tissue by near infra-red imaging  with a camera dictated  to identify the margin of the tumor, and Histological detection of  indocyanine  green distribution in tumor bearing breasts and in axillary pieces of dissection and the detection of tumor cells in lymphe nodes.", 
            "measure": "Study of the evantual difference of indocyanine in mammalian tissue in patients mastocmemezied for breast canrcinoma.", 
            "safety_issue": "No", 
            "time_frame": "10 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01993576"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Detecting the fluorescence in between benign and malignant tissue by a microscope with a filter for near ifra-red at a good wave length of ICG.", 
            "measure": "Microscopical detection of indocyanine green in breast tissue.", 
            "safety_issue": "No", 
            "time_frame": "10 months."
        }, 
        "source": "Jules Bordet Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Jules Bordet Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}